selected publications
-
academic article
- Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database.. BMC cardiovascular disorders. 21:-. 2021
- Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.. Circulation. 143:e254-e743. 2021
- Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association. Circulation. 2021
- Polypharmacy, Adverse Outcomes, and Treatment Effectiveness in Patients ≥75 With Atrial Fibrillation.. Journal of the American Heart Association. 9:-. 2020
- Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.. The American journal of medicine. 133:e554-e567. 2020
- Sex and racial differences in cardiovascular disease risk in patients with atrial fibrillation.. PloS one. 14:-. 2019
- A new model to predict ischemic stroke in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. Heart rhythm. 16:820-826. 2018
- Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation.. Journal of the American Heart Association. 7:-. 2018
- Provider Specialty, Anticoagulation, and Stroke Risk in Patients With Atrial Fibrillation and Cancer.. Journal of the American College of Cardiology. 72:1913-1922. 2018
- A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.. PloS one. 13:-. 2018
- Influence of Sociodemographic Factors and Provider Specialty on Anticoagulation Prescription Fill Patterns and Outcomes in Atrial Fibrillation.. The American journal of cardiology. 122:388-394. 2018
- Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.. Journal of the American Heart Association. 7. 2018
- Oral anticoagulants and liver injury: the threat of uncontrolled confounding.. Heart (British Cardiac Society). 104:-. 2018
- Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.. BMC cardiovascular disorders. 17:-. 2017
- Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation.. Heart (British Cardiac Society). 103:834-839. 2017